Aptose Biosciences to Host Key Opinion Leader Event Present at BIO CEO & Investor Conference
January 29, 2020 07:30 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, Jan. 29, 2020 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the...
Aptose Reports Results for the Second Quarter Ended June 30, 2019
August 06, 2019 16:00 ET
|
Aptose Biosciences, Inc.
─ APTO-253 Inhibits MYC in AML and MDS Patients in Phase 1 Clinical Trial ─ ─ First CLL Patient Dosed with CG-806 in Phase 1 Clinical Trial ─ Conference Call and Webcast at 5pm EDT Today ...
Aptose Biosciences to Present at Canaccord Genuity 39th Annual Growth Conference
July 30, 2019 07:30 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, July 30, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting the...
Aptose To Release Second Quarter Ended June 30, 2019 Financial Results and Hold Conference Call on August 6, 2019
July 23, 2019 07:30 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, July 23, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology company developing first-in-class agents that target the...
Aptose Biosciences Announces Results of Annual and Special Meeting of Shareholders
June 04, 2019 16:02 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, June 04, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated...
Aptose Appoints Jotin Marango, M.D., Ph.D. as Chief Business Officer
June 03, 2019 09:00 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, June 03, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting the...
Aptose Announces Closing of Public Offering of Common Shares
June 03, 2019 08:38 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, June 03, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), today announced the closing of its previously announced...
Aptose to Present at the Jefferies 2019 Healthcare Conference
May 31, 2019 08:00 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, May 31, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology company developing first-in-class agents that target the...
Aptose Announces Pricing of Public Offering of Common Shares
May 30, 2019 09:01 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, May 30, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), today announced that it priced its previously announced...
Aptose to Present at May Investor Conferences
May 13, 2019 08:15 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, May 13, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology company developing first-in-class agents that target the...